Dietary Management of Diabetes Mellitus in Europe and North America
J.I. Mann
University of Otago, Dunedin, New Zealand
Diabetes Service, Dunedin Hospital, Dunedin, New Zealand
Search for more papers by this authorN.J. Lewis-Barned
University of Newcastle Medical School, Tyne, UK
North Tyneside General Hospital, Tyne and Wear, UK
Search for more papers by this authorJ.I. Mann
University of Otago, Dunedin, New Zealand
Diabetes Service, Dunedin Hospital, Dunedin, New Zealand
Search for more papers by this authorN.J. Lewis-Barned
University of Newcastle Medical School, Tyne, UK
North Tyneside General Hospital, Tyne and Wear, UK
Search for more papers by this authorAbstract
The Japanese diet is widely known to be a healthy one, with a low risk for causing cardiovascular disease. Historically rooted, Japanese gastronomic culture is unique, and includes a wide variety of foodstuffs, original flavoring recipes, and fermentation methods. A distinctive Food Guide Pyramid for Japanese people and a meal log chart, evaluating eight major treatment assessments, have been created to aid dietary guidance. The results are represented diagrammatically in this chapter, with each of the treatment assessments being scored. Straightforward to understand, this guidance is stress-free for the patient and helps ensure that the patient follows the appropriate dietary regimen.
Since diabetes treatment not only involves blood glucose level monitoring, but also the evaluation of the disease's complications course, the treatment assessments are made on a 3–6-months timeframe. The case study results indicate that the dietary guidance based on the Food Guide Pyramid is useful and beneficial for treatment of the disease.
References
- 1 Diabetes and Nutrition Study Group of the European Association for the Study of Diabetes. Recommendations for the nutritional management of patients with diabetes mellitus. Eur J Clin Nutr 2000; 54: 353–5.
- 2 American Diabetes Association. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 2003; 26 (suppl 1): S51–61.
- 3 Franz MJ, Bantle JP, Beebe CA, Brunzell JD, Chiasson J-L, Garg A, Holzmeister LA, Hoogwerf B, Mayer-Davis E, Mooradian AD, Purnell JQ, Wheeler M. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 2002; 25: 148–98.
- 4 Goldstein DJ. Beneficial health effects of modest weight loss. Int J Obes 1992; 16: 397–415.
- 5 Yudkin JS. How can we best prolong life? The benefits of coronary risk factor reduction in non-diabetic and diabetic subjects. BMJ 1993; 306: 1313–8.
- 6 Prewitt TE, Schmeisser D, Bowen PE, Aye P, Dolecek TA, Langenberg P, Cole T, Brace L. Changes in body weight, body composition, and energy intake in women fed high- and low-fat diets. Am J Clin Nutr 1991; 54: 304–10.
- 7 Miller WC, Linderman AK, Wallace J, Niederpruem M. Diet composition, energy intake, and exercise in relation to body fat in men and women. Am J Clin Nutr 1990; 52: 426–30.
- 8 Dreon DM, Frey-Hewitt B, Ellsworth N, Williams PT, Terry RB, Wood PD. Dietary fat: carbohydrate ratio and obesity in middle-aged men. Am J Clin Nutr 1988; 47: 995–1000.
- 9 Henry RR, Wallace P, Olefsky JM. Effects of weight loss on mechanisms of hyperglycaemia in obese non-insulin dependent diabetes mellitus. Diabetes 1986; 35: 990–8.
- 10 Henry RR, Schaeffer L, Olefsky JM. Glycaemic effects of intensive calorie restriction and iso-caloric refeeding in non-insulin dependent diabetes mellitus. J Clin Endocrinology 1985; 61: 917–25.
- 11 Henry RR, Wiest-Kent TA, Schaeffer L, et al. Metabolic consequences of very-low-calorie diet therapy in obese non-insulin dependent diabetic and non-diabetic subjects. Diabetes 1986; 35: 155–64.
- 12 Olefsky J, Reaven GM, Farquhar JW. Effects of weight reduction on obesity: studies of lipid and carbohydrate metabolism in normal and hyperlipidaemic subjects. J Clin Invest 1974; 53: 64–76.
- 13 Kern PA, Trozzolino L, Wolfe G, Purdy L. Combined use of behavior modification and very-low-calorie diet in weight loss and weight maintenance. Am J Med Sci 1994; 307: 325–8.
- 14 Anderson JW, Hamilton CC, Brinkman-Kaplan V. Benefits and risks of an intensive very-low-calorie diet program for severe obesity. Am J Gastroenterol 1992; 87: 6–15.
- 15 Wing RR, Marcus MD, Blair EH, Burton LR. Psychological responses of obese type 2 diabetic subjects to very-low-calorie diet. Diabetes Care 1991; 14: 596–9.
- 16 Henry RR, Gumbiner B. Benefits and limitations of very-low-calorie diet therapy in obese NIDDM. Diabetes Care 1991; 14: 802–23.
- 17 Hughes VA, Fiatarone MA, Fielding RA, Kahn BB, et al. Exercise increases muscle Glut-levels and insulin action in subjects with impaired glucose tolerance. Am J Physiol 1993; 264: E855–62.
- 18 Barnard RJ, Ugianskis EJ, Martin DA, Inkeles SB. Role of diet and exercise in the management of hyperinsulinemia and associated atherosclerotic risk factors. Am J Cardiol 1992; 69: 440–4.
- 19 Moy CS, Songer TJ, LaPorte RE, et al. Insulin dependent diabetes mellitus, physical activity and death. Am J Epidemiol 1993; 137: 74–81.
- 20 Zock PL, de Vries HM, Katan MB. Impact of myristic acid versus palmitic acid on serum lipid and lipoprotein levels in healthy women and men. Arterioscler Thromb 1994; 14: 567–75.
- 21 Mensink RP, Katan MB. Effect of dietary trans fatty acids on high-density lipoprotein cholesterol levels in healthy subjects. N Engl J Med 1990; 323: 439–45.
- 22 Zock PL, Katan MB. Hydrogenation alternatives: effects of trans fatty acids and stearic acid versus linoleic acid on serum lipids and lipoprotein in humans. J Lipid Res 1992; 33: 399–410.
- 23 Mensink RP, Zock PL, Katan MB, Hornstra G. Effect of dietary cis and trans fatty acids on serum lipoprotein(a) levels in humans. J Lipid Res 1992; 33: 1493–501.
- 24 Nestel P, Noakes M, Belling B, McArthur R, Clifton P, Janus E, Abbey M. Plasma lipoprotein lipid and Lp(a) changes with substitution of elaidic acid for oleic acid in the diet. J Lipid Res 1992; 33: 1029–36.
- 25 Willett WC, Stampfer MJ, Manson JE, Colditz GA, et al. Intake of trans fatty acids and risk of coronary heart disease among women. Lancet 1993; 341: 581–5.
- 26 Foley M, Ball M, Chisholm A, Duncan A, Spears G, Mann J. Should mono- or polyunsaturated fats replace saturated fat in the diet? Eur J Clin Nutr 1992; 46: 429–36.
- 27 Rillaerts EG, Engelmann GJ, van Camp KM, De Leeuw I. Effect of omega-3 fatty acids in diet of type 1 diabetic subjects on lipid values and haemorrheological parameters. Diabetes 1989; 38: 1412–6.
- 28 Popp-Snijders C, Schouten JA, Heine RJ, van der Meer J, van der Veen EA. Dietary supplementation of omega-3 polyunsaturated fatty acids improves insulin sensitivity in non-insulin dependent diabetes. Diabetes Res 1987; 4: 141–7.
- 29 Jones DB, Haitas B, Bown EG, Carter RD, Barker K, Jelfs R, Turner RC, Mann JI, Prescott RJ. Platelet aggregation in non-insulin dependent diabetes in association with platelet fatty acids. Diabet Med 1986; 3: 52–5.
- 30 Mori TA, Vandongen R, Masarei JR, Stanton KG, Dunbar D. Dietary fish oil increases serum lipids in insulin-dependent diabetes compared with healthy controls. Metabolism 1989; 38: 404–9.
- 31 Schetchman G, Kaul S, Kissebah AH. Effect of fish oil concentrate on lipoprotein composition in NIDDM. Diabetes 1988; 37: 1567–73.
- 32 Garg A, Bonanome A, Grundy SM, Zhang Z-J, Unger RH. Comparison of a high-carbohydrate diet with a high-monounsaturated-fat diet in patients with non-insulin dependent diabetes mellitus. N Engl J Med 1988; 391: 829–34.
- 33 Garg A, Reaven GM, Bantle JP, Griver K. Multi centre diet study group. Long-term effects of high carbohydrate versus high MUFA diets in NIDDM. Diabetes 1992; 41 (suppl 1): 72A.
- 34 Parillo M, Rivellese AA, Ciardullo AV, Capaldo B, Giacco A, Genovese S, Riccardi G. A high-mono-unsaturated-fat/low-carbohydrate diet improves peripheral insulin sensitivity in non-insulin dependent diabetic patients. Metabolism 1992; 41: 1373–8.
- 35 Mann JI. Diet and diabetes. Diabetologia 1980; 18: 89–95.
- 36 Kiehm TG, Anderson JW, Ward K. Beneficial effects of a high carbohydrate, high fibre diet on hyperglycaemic men. Am J Clin Nutr 1976; 29: 895–9.
- 37 Jenkins DJA, Wolever TMS, Haworth R, Leeds AR, Hockaday TDR. Guar gum in diabetes. Lancet 1976; 2: 1086–7.
- 38 Jenkins DJA, Leeds AR, Gassull MA, Cochet B, Alberti KGMM. Decrease in postprandial insulin and glucose concentrations for guar and pectin. Ann Intern Med 1977; 86: 20–3.
- 39 Aro A, Uusitupa M, Voutilainen E, et al. Improved diabetic control and hypocholesterolaemic effect induced by long-term supplementation with guar in type 2 diabetics. Diabetologia 1981; 21: 29–33.
- 40 Vinik AI, Jenkins DJA. Dietary fibre in the management of diabetes. Diabetes Care 1988; 11: 160–73.
- 41 Peterson DB, Mann JI. Guar: pharmacological fibre or food fibre? Diabet Med 1985; 2: 345–7.
- 42 Lousley SE, Jones DB, Slaughter P, Carter RD, Jelfs R, Mann JI. High carbohydrate/high fibre diets in poorly controlled diabetes. Diabet Med 1984; 1: 21–5.
- 43 Simpson HCR, Simpson RW, Lousley S, Carter RD, Geekie M, Hockaday TD, Mann JI. A high carbohydrate leguminous fibre diet improves all aspects of diabetic control. Lancet 1981; 1: 1–5.
- 44 Chandalia M, Garg A, Lutjohann D, von Bergmanm K, Grundy SM, Brinkley LJ. Beneficial effects of high dietary fibre intake in patients with type 2 diabetes. N Engl J Med 2000; 342 (19): 1392–8.
- 45 Riccardi G, Rivellese A, Pacioni D, Genovese D, Mastranzo P, Mancini M. Separate influence of dietary carbohydrate and fibre on the metabolic control in diabetes. Diabetologia 1984; 26: 116–21.
- 46 Simpson HCR, Carter RD, Lousley S, Mann JI. Digestible carbohydrate—an independent effect on diabetic control in type 2 (non-insulin dependent) diabetic patients? Diabetologia 1982; 23: 235–9.
- 47 Geekie MA, Porteous J, Hockaday TDR, Mann JI. Acceptability of high-fibre diets in diabetic patients. Diabet Med 1986; 3: 52–5.
- 48 McCulloch DK, Mitchell RD, Ambler J, Tattersall RB. A prospective comparison of ‘conventional’ and high carbohydrate/high fibre/low fat diets in adults with established type 1 (insulin-dependent) diabetes. Diabetologia 1985; 28: 208–12.
- 49 Peterson DB, Lambert J, Gerring S, Darling P, Carter RD, Jerfs R, Mann JI. Diabetologia 1986; 29: 216–20.
- 50 Anderson JW, Story LJ, Zettwoch NC, Gustafson NJ, Jefferson BS. Metabolic effects of fructose supplementation in diabetic individuals. Diabetes Care 1989; 12: 337–44.
- 51 Crapo PA, Kolterman OG, Henry RR. Metabolic consequence of two-week fructose feeding in diabetic subjects. Diabetes Care 1986; 9: 111–9.
- 52 Born P, Eimiller A, Paul F. High rate of gastrointestinal side effects in fructose-consuming patients. Diabetes Care 1987; 10: 376–7.
- 53 Dills WL. Protein fructosylation: fructose and the Maillard reaction. Am J Clin Nutr 1993; 58 (suppl): 779S–87S.
- 54 Jenkins DJA, Wolever TMS, Jenkins AL. Starchy foods and glycemic index. Diabetes Care 1988; 11: 149–59.
- 55 Kolata G. Diabetics should lose weight, avoid fad diets. Science 1987; 235: 163–4.
- 56 Thorburn AW, Brand JC, Truswell AS. The glycaemic index of foods. Med J Aust 1986; 144: 580–2.
- 57 Gannon MC, Nuttall FQ. Factors affecting interpretation of postprandial glucose and insulin areas. Diabetes Care 1987; 10: 754–63.
- 58 Brand-Miller J, Hayne S, Petocz, Colagiuri S, Low-glycemic index diets in the management of diabetes: a meta-analysis of randomized controlled diets. Diabetes Care 2003; 26: 2261–7.
- 59 Järvi AE, Karlström BE, Granfeldt YE, Björck IE, Asp N-GL, Vessby BOH. Improved glycemic control and lipid profile and normalized fibrololytic activity on a low-glycemic index diet in type 2 diabetic patients. Diabetes Care 1999; 22: 10–8.
- 60 Dullaart RP, Beusekamp BJ, Meijer S, van-Doormaal JJ, Sluiter WJ. Long-term effects of protein-restricted diet on albuminuria and renal function in IDDM patients without clinical nephropathy and hypertension. Diabetes Care 1993; 16: 483–92.
- 61 Jones SL, Kontessis P, Wiseman M, Dodds R, Bognetti E, Pinto J, Viberti G. Protein intake and blood glucose as modulators of GFR in hyperfiltering diabetic patients. Kidney Int 1992; 41: 1620–8.
- 62 Keller K, Whittaker E, Sullivan L, Raskin P, Jacobson HR. Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus. N Engl J Med 1991; 324: 78–84.
- 63 Evanoff G, Thompson C, Brown J, Weinman E. Prolonged dietary protein restriction in diabetic nephropathy. Arch Intern Med 1989; 149: 1129–33.
- 64 Walker JD, Bending JJ, Dodds RA, Mattock MB, Murrells TJ, Keen H, Viberti GC. Restriction of dietary protein and progression of renal failure in diabetic nephropathy. Lancet 1989; 2 (8677): 1411–5.
- 65 Ciavarella A, Di Mizio G, Stefoni S, et al. Reduced albuminuria after dietary protein restriction in insulin dependent diabetic patients with clinical nephropathy. Diabetes Care 1987; 10: 407–13.
- 66 Pomerleau J, Verdy M, Garrel DR, Nadeau MH. Effect of protein intake on glycaemic control and renal function in type 2 (non-insulin dependent) diabetes mellitus. Diabetologia 1993; 36: 829–34.
- 67 Brodsky IG, Robbins DC, Hiser E, Fuller SP, Fillyaw M, Devlin JT. Effects of low-protein diets on protein metabolism in insulin-dependent diabetes mellitus patients with early nephropathy. J Clin Endocrinol Metab 1992; 75: 351–7.
- 68 Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G, for the Modification of Diet in Renal Disease Study Group. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med 1994; 330: 877–84.
- 69 Jibani MM, Bloodworth LL, Foden E, Griffiths KD, Galpin OP. Predominantly vegetarian diet in patients with incipient and early clinical diabetic nephropathy: effects on albumin excretion rate and nutritional status. Diabet Med 1991; 8: 949–53.
- 70 Walter RM, Uriu-Hare JY, Lewis Olin K, Oster MH, Anawalt BD, Critchfield JW, Keen CL. Copper, zinc, manganese, and magnesium status and complications of diabetes mellitus. Diabetes Care 1991; 14: 1050–6.
- 71 American Diabetes Association. Treatment of hypertension in adults with diabetes. Diabetes Care 2003; 26 (suppl 1): S80–2.
- 72 Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and risk of coronary heart disease in men. N Engl J Med 1993; 328: 1450–6.
- 73 Paolisso G, D'Amore A, Galzerano D, Balbi V, et al. Daily vitamin E supplements improve metabolic control but not insulin secretion in elderly type 2 diabetic patients. Diabetes Care 1993; 16: 1433–7.
- 74 Ceriello A, Guigliano D, Quatraro A, Donzella C, Dipalo G, Lefebvre PJ. Vitamin E reduction of protein gly-cosylation in diabetes. Diabetes Care 1991; 14: 68–72.
- 75 Christiansen C, Thomsen C, Rasmussen O, Balle M, Hauerslev C, Hansen C, Hermansen K. Wine for type 2 diabetic patients? Diabet Med 1993; 10: 958–61.
- 76 Koivisto VA, Tulokas S, Toivonen M, Haapa E, Pelkonen R. Alcohol with a meal has no adverse effects on post-prandial glucose homeostasis in diabetic patients. Diabetes Care 1993; 16: 1612–4.